OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44 | -99.9% | 15,814 | +19.1% | 0.00% | -20.0% |
| Q3 2022 | $55,000 | -73.9% | 13,274 | -37.0% | 0.01% | -80.0% |
| Q3 2021 | $211,000 | -37.2% | 21,066 | -11.1% | 0.02% | -26.5% |
| Q2 2021 | $336,000 | -1.8% | 23,702 | +13.8% | 0.03% | -12.8% |
| Q1 2021 | $342,000 | +12.5% | 20,828 | -47.9% | 0.04% | -20.4% |
| Q3 2020 | $304,000 | +192.3% | 39,974 | +90.7% | 0.05% | +145.0% |
| Q1 2020 | $104,000 | +23.8% | 20,960 | -0.6% | 0.02% | +33.3% |
| Q4 2018 | $84,000 | -56.9% | 21,077 | +0.1% | 0.02% | -67.4% |
| Q1 2017 | $195,000 | -34.1% | 21,062 | -40.6% | 0.05% | -41.8% |
| Q4 2016 | $296,000 | – | 35,458 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |